The highest rate of diagnosis is among individuals ages 60-69
Mumbai, India, March 21, 2026: Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharma and includes its subsidiaries and/or associate companies) today announced the launch of its semaglutide injection under the brand names Noveltreat and Sematrinity in India, in all strengths
Annual plans offer tiered access to biomarker testing and virtual clinical follow up, designed to deepen engagement and enable cross selling of additional treatments
Samhani C, Guerci B, Larose C
First discovered in human plasma in the 1970s, it plays a vital role in signaling tissue remodeling and wound healing
Compare compounds: See our Retatrutide vs Semaglutide and Retatrutide vs Tirzepatide vs Semaglutide research comparisons for receptor profile and efficacy data